Company Overview

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

  • Name

    Abbott Laboratories

  • CEO

    Mr. Robert B. Ford

  • Website

    www.abbott.com

  • Sector

    Health Care Equipment and Supplies

  • Year Founded

    1888

Profile

  • Market Cap

    $198.61B

  • EV

    $206.48B

  • Shares Out

    1,739.9M

  • Revenue

    $40.73B

  • Employees

    114,000

Margins

  • Gross

    55.47%

  • EBITDA

    25.96%

  • Operating

    17.98%

  • Pre-Tax

    15.98%

  • Net

    13.65%

  • FCF

    13.88%

Returns (5Yr Avg)

  • ROA

    7.77%

  • ROTA

    27.48%

  • ROE

    16.22%

  • ROCE

    12.17%

  • ROIC

    11.46%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    $124.12

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    $7,219M

  • Net Debt

    $7,626M

  • Debt/Equity

    0.38

  • EBIT/Interest

    12.09

Growth (CAGR)

  • Rev 3Yr

    0.41%

  • Rev 5Yr

    5.65%

  • Rev 10Yr

    7.56%

  • Dil EPS 3Yr

    -3.7%

  • Dil EPS 5Yr

    14.28%

  • Dil EPS 10Yr

    7.47%

  • Rev Fwd 2Yr

    5.65%

  • EBITDA Fwd 2Yr

    6.87%

  • EPS Fwd 2Yr

    7.59%

  • EPS LT Growth Est

    8.45%

Dividends

  • Yield

  • Payout

    67.91%

  • DPS

    $2.16

  • DPS Growth 3Yr

    8.1%

  • DPS Growth 5Yr

    11.74%

  • DPS Growth 10Yr

    10.44%

  • DPS Growth Fwd 2Yr

    7.17%

NYSE:ABT